Elective neck dissection versus observation in primary parotid carcinoma

被引:89
作者
Zbären, P [1 ]
Schüpbach, J
Nuyens, M
Stauffer, E
机构
[1] Univ Hosp Bern, Dept Otorhinolaryngol Head & Neck Surg, CH-3000 Bern, Switzerland
[2] Univ Hosp Bern, Dept Pathol, CH-3000 Bern, Switzerland
关键词
D O I
10.1016/j.otohns.2004.09.029
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
OBJECTIVE. To evaluate the efficacy of elective neck dissection in the clinically negative neck of patients with primary carcinoma of the parotid gland. STUDY DESIGN AND SETTING: A retrospective analysis was undertaken at a university Department of Otorhinolaryngology-Head and Neck Surgery on 83 previously untreated patients with primary carcinoma of the parotid gland and a clinically negative neck. The reliability of fine needle aspiration cytology, frozen section, and the clinico-pathologic findings of patients with occult neck metastases were analyzed. The regional recurrence rate and the outcome were compared among 2 groups; one with elective neck dissection (N = 41) and one without elective neck dissection (N = 42). RESULTS: The diagnosis of malignancy was known preoperatively in 59 (71%) cases, the exact histologic tumor type in 36 (43%) and the grade in 37 (44%) of 83 cases. Occult metastases were detected in 8 (20%) of 41 cNO patients, in 5 cases associated with a high-grade and in 3 cases with a low-grade carcinoma. Recurrence of disease developed in 5 (12%) patients in the elective neck dissection group and in 11 (26%) patients in the observation group. All of the 7 neck recurrences occurred in the observation group. The 5-year actuarial and disease-free survival rate was 80% and 86% for patients with elective neck dissection and 83% and 69% for patients without neck dissection. CONCLUSION AND SIGNIFICANCE: A routine elective neck dissection is suggested in all patients with primary carcinoma of the parotid gland. The efficacy of elective neck dissection, nevertheless, has never been evaluated prospectively.
引用
收藏
页码:387 / 391
页数:5
相关论文
共 25 条
[1]  
Al-Khafaji BM, 1998, CANCER CYTOPATHOL, V84, P153, DOI 10.1002/(SICI)1097-0142(19980625)84:3<153::AID-CNCR6>3.3.CO
[2]  
2-7
[3]  
ARMSTRONG JG, 1992, CANCER, V69, P615, DOI 10.1002/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO
[4]  
2-9
[5]   MALIGNANT EPITHELIAL PAROTID TUMORS - A RATIONAL TREATMENT POLICY [J].
BALL, ABS ;
FISH, S ;
THOMAS, JM .
BRITISH JOURNAL OF SURGERY, 1995, 82 (05) :621-623
[6]   TUMORS OF PAROTID GLAND [J].
BARDWIL, JM .
AMERICAN JOURNAL OF SURGERY, 1967, 114 (04) :498-&
[7]  
BYERS RM, 1982, RESIDENT STAFF PHYS, V4, P52
[8]   Management of the neck in cancer of the major salivary glands, thyroid and parathyroid glands [J].
Ferlito, A ;
Pellitteri, PK ;
Robbins, KT ;
Shaha, AR ;
Kowalski, LP ;
Silver, CE ;
Anniko, M ;
Rinaldo, A ;
Medina, JE ;
Bradley, PJ ;
Byers, RM .
ACTA OTO-LARYNGOLOGICA, 2002, 122 (06) :673-678
[9]  
FRANKENTHALER RA, 1993, ARCH OTOLARYNGOL, V119, P517
[10]   Management of the neck in parotid carcinoma [J].
Kelley, DJ ;
Spiro, RH .
AMERICAN JOURNAL OF SURGERY, 1996, 172 (06) :695-697